drugset / Trial / NCT00756002
Safety and Efficacy Study of Ramelteon in Subjects With Chronic Insomnia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the safety and efficacy of 4 mg of Ramelteon, once daily (QD), in subjects with chronic insomnia.
Timeline
- Start
- 2007-08
- Primary completion
- 2008-03
- Completion
- 2008-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ramelteon | Unknown | 4 mg | Oral |